Does failure to perform prophylactic level VI node dissection leave persistent disease detectable by ultrasonography in patients with low-risk papillary carcinoma of the thyroid?

Surgery

Volumn 146, Issue 6, 2009, Pages 1182-1187

  Monchik, Jack M ^a   Simon, Caroline J ^a   Caragacianu, Diana L ^a   Thomay, Alan A ^a   Tsai, Vicki ^a   Cohen, Jonah ^a   Mazzaglia, Peter J ^a  

^a RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROGLOBULIN;

ADULT; AGED; ARTICLE; CANCER RISK; ECHOGRAPHY; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROPHYLAXIS; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; THYROIDECTOMY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK FACTORS; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY; YOUNG ADULT;

EID: 70549099890     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2009.10.024     Document Type: Article

References (15)

1. Sherman S.I. Thyroid carcinoma. Lancet 361 (2003) 501-511
2. Machens A., Hinze R., Thomusch O., and Dralle H. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 26 (2002) 22-28
3. Grodski S., Cornford L., Sywak M., Sidhu S., and Delbridge L. Routine level VI lymph node dissection for papillary thyroid cancer: surgical technique. ANZ J Surg 77 (2007) 203-208
4. Cooper D.S., Doherty G.M., Haugen B.R., Kloos R.T., Lee S.L., Mandel S.J., et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16 (2006) 109-142
5. White M.L., Gauger P.G., and Doherty G.M. Central lymph node dissection in differentiated thyroid cancer. World J Surg 31 (2007) 895-04
6. Swyak M., Cornford L., Roach P., Stalberg P., Sidhu S., and Delbridge L. Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 140 (2006) 1000-1007
7. Hay I.D., McConahey W.M., and Goellner J.R. Managing patients with papillary thyroid carcinoma. Insights gained from the May Clinic's experience of treating 2,512 consecutive patients during 1940-2000. Trans Amer Clin Climatol Assoc 113 (2002) 241-260
8. Kouvaraki M.A., Shapiro S.E., Fornage B.D., Edelken-Monro S.S., Vassilopoulou-Sellin R., et al. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery 134 (2003) 946-954
9. Musacchio M.J., Kim A.W., Visungco J.D., and Prinz R.A. Greater local recurrences occurs with "berry picking" then neck dissection in thyroid cancer. Am Surg 69 (2003) 191-196
10. Davies L., and Welch H.G. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295 (2006) 2164-2167
11. Hay I.D., Hutchinson M.E., Gonzalez-Losanda M.B., Reinalda M.E., et al. Papillary microcarcinoma: a study of 900 cases observed in a 6-year period. Surgery 114 (2008) 980-988
12. Hay I.D. Management of patients with low-risk papillary thyroid carcinoma. Endocr Pract 13 (2007) 521-533
13. Henry J.F., Gramatica L., Denizot A., Kvachenyuk A., Puccini M., and Defechereux T. Morbidity of prophylacticlymph node dissection in the central neck area in patients with papillary thyroid carcinoma. Langenbecks Arch Surg 383 (1998) 167-169
14. Dupuy D.E., Monchik J.M., Decrea C., and Pisharodi L. Radiofrequency ablation of regional recurrence from well differentiated thyroid malignancy. Surgery 130 (2001) 371-377
15. Monchik J.M., Donatini G., Iannucilli J., and Dupuy D.E. Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma. Ann Surg 244 (2006) 296-304